Table 1 Participant demographics.

From: Expression of type I interferon-associated genes at antiretroviral therapy interruption predicts HIV virological rebound

 

Week 0 (n = 11)

Week 48 (n = 14)

Sex

 Female

11

14

 Male

Country

 South Africa

11

12

 UK

1

 Uganda

1

Rebound group

 Early rebounder (ER)—< 100 days

4

5

 Post treatment controller (PTC) > 100 days

7

9

  1. Number of participants with samples available for analysis at Week 0 and 48. Numbers of participants analysed by sex, country of origin and clinical rebound timing.